Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
Holding PTCT?
Track your performance easily
See the Price Targets and Ratings of:
PTCT Analyst Ratings
Moderate Buy
7 Buy
5 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PTCT Stock 12 Month Forecast
Average Price Target
$40.00
▲(12.74% Upside)
| Highest Price Target$64.00 | Average Price Target$40.00 | Lowest Price Target$26.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Cantor Fitzgerald
Reiterated
09/16/24
Morgan Stanley
Assigned
09/05/24
TD Cowen
Reiterated
09/05/24
Robert W. Baird
Initiated
09/03/24
Leerink Partners
Reiterated
08/12/24
Barclays
Reiterated
08/09/24
Citi
Reiterated
08/09/24
William Blair
Reiterated
08/09/24
RBC Capital
Assigned
08/08/24
Goldman Sachs
$32
Sell
-9.81%
Downside
Reiterated
08/08/24
Maintained Sell Rating for PTC Therapeutics Amidst Sales Shortfall and Regulatory Hurdles
J.P. Morgan
$53→$51
Buy
43.74%
Upside
Assigned
08/08/24
PTC Therapeutics price target lowered to $51 from $53 at JPMorganPTC Therapeutics price target lowered to $51 from $53 at JPMorgan
Wells Fargo
$56
Buy
57.84%
Upside
Reiterated
08/08/24
Buy Rating Affirmed for PTC Therapeutics on Strong Q2 Performance and Promising Pipeline
Bank of America Securities
$32
Sell
-9.81%
Downside
Reiterated
06/28/24
Recommended Sell Rating on PTC Therapeutics Due to Regulatory Challenges and Pipeline Risks
Jefferies
$46→$43
Buy
21.20%
Upside
Reiterated
06/28/24
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (NASDAQ: PTCT), Structure Therapeutics, Inc. Sponsored ADR (NASDAQ: GPCR) and UnitedHealth (NYSE: UNH)
Best Analysts Covering PTC Therapeutics
Which Analyst Should I Follow If I Want to Buy PTCT and Sell After:
1 Month
xxx
Success Rate
10/14 ratings generated profit
Average Return
+4.49%
initiated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +4.49% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+1.37%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +1.37% per trade.
1 Year
Success Rate
12/14 ratings generated profit
Average Return
+36.40%
initiated a buy rating 17 days ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +36.40% per trade.
2 Years
xxx
Success Rate
12/14 ratings generated profit
Average Return
+58.89%
initiated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +58.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PTCT Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
3
4
7
5
Buy
11
12
9
7
3
Hold
14
13
9
10
9
Sell
8
11
9
7
2
Strong Sell
0
0
0
0
0
total
33
39
31
31
19
Each month's total comprises the sum of three months' worth of ratings.
PTCT Financial Forecast
PTCT Stock Forecast FAQ
What is PTCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PTC Therapeutics’s 12-month average price target is $40.00.
What is PTCT’s upside potential, based on the analysts’ average price target?
PTC Therapeutics has 12.74% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTCT a Buy, Sell or Hold?
PTC Therapeutics has a consensus rating of Moderate Buy which is based on 7 buy ratings, 5 hold ratings and 3 sell ratings.
What is PTC Therapeutics’s price target?
The average price target for PTC Therapeutics is $40.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $64.00 ,the lowest forecast is $26.00. The average price target represents 12.74% Increase from the current price of $35.48.
The highest analyst price target is $64.00 ,the lowest forecast is $26.00. The average price target represents 12.74% Increase from the current price of $35.48.
What do analysts say about PTC Therapeutics?
PTC Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of PTCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.